USFDA issues final guidance on voluntary recalls

The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem

We plan to expand into the US market this year: Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals

Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward

Brinton ties up with Scholl Wellness Company

Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream

IIFL AMC funds acquire stake in OmniActive Health Technologies

OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation

Univar Solutions opens latest Solution Centre for its global ecosystem of innovation

State-of-the-art laboratory to support ingredient and specialty chemical innovation, product formulation application development and more sustainable solutions across Europe and beyond

Myonex acquires clinical trial and drug wholesale business of Hubertus in Berlin

Clinical trial supply company strengthens its presence in the European Union

Novavax ships first consignment of Covid-19 vaccine to European countries

The first wave of shipments includes several countries, such as Germany, France and Austria

Azelis expands partnership with Roquette to strengthen India presence

This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.

Prestige BioPharma’s Tuznue receives EU-GMP certification

Prestige BioPharma’s facility receives EU-GMP certification

The facility will manufacture its Herceptin biosimilar, Tuznue